Bay Street News, February, 2024

NOVI, Mich., Feb. 01, 2024 (GLOBE NEWSWIRE) — The Shyft Group, Inc. (NASDAQ: SHYF) (“Shyft” or the “Company”), the North […]

Sales increased 3% to $4.8 billion; organic sales increased 3% Segment operating margin was 21.1%, or a record 24.5% adjusted, […]

WALTHAM, Mass., Feb. 01, 2024 (GLOBE NEWSWIRE) — Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on […]

TROY, Mich., Feb. 01, 2024 (GLOBE NEWSWIRE) — Kelly, a leading global specialty talent solutions provider, will release its fourth-quarter […]

CINCINNATI, Feb. 01, 2024 (GLOBE NEWSWIRE) — Quipt Home Medical Corp. (the “Company”) (NASDAQ: QIPT) (TSX: QIPT), a U.S. based […]

REHOVOT, Israel, Feb. 01, 2024 (GLOBE NEWSWIRE) — Purple Biotech Ltd. (“Purple Biotech” or “the Company”) (NASDAQ/TASE: PPBT), a clinical-stage […]

CINCINNATI, Feb. 01, 2024 (GLOBE NEWSWIRE) — Hillman Solutions Corp. (Nasdaq: HLMN) (“Hillman”), a leading provider of hardware products and […]

NEW YORK, Feb. 01, 2024 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage […]

– On track for PDUFA target action date of May 25, 2024 – CLEVELAND, Feb. 01, 2024 (GLOBE NEWSWIRE) — […]

Highlights: Clarion’s Head of Psychiatry, Professor Suresh Sundram, has been approved by the TGA to prescribe MDMA for Post-traumatic Stress […]